Reach Of Prometheus Will Come Into Focus In Myriad Ruling
Friday's oral arguments in the closely watched case over the patentability of breast cancer genes isolated by Myriad Genetics Inc. will provide the first hints on how broadly the Federal Circuit...To view the full article, register now.
Already a subscriber? Click here to view full article